Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05246930 · ClinicalTrials.gov registry record
Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 43
- Enrollment target
NCT05246930: Completed study, sponsored by University of Rochester.
NCT05246930 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05246930 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.
Primary Outcome
The oscillometer will collect an airway impedance measurement which is made up of multiple variables.
Interventions
- DEVICE Impulse Oscillometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2024-12-01 |
What the finished NCT05246930 record still lists
NCT05246930 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Impulse Oscillometer is the first listed.
NCT05246930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05246930 about?
NCT05246930 is a clinical study titled "Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma". This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.
What is the current status of trial NCT05246930?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2022-06-15. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05246930?
The interventions under investigation include: Impulse Oscillometer (DEVICE).
Who is sponsoring clinical trial NCT05246930?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI